PLANT

Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt

The investment will pave the way for the construction of a 36,000-square-metre facility that will replace Sanofi's current insulin production plant in Frankfurt's Hoechst district by 2029, the company said.